Federal contract award
W81XWH21C0075
FY20 NEW START-JW200215-IMPROVING NEUROTRAUMA BY DEPOLARIZATION INHIBITION WITH COMBINATION THERAPY (INDICT): A PHASE 2 RANDOMIZED TRIAL
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W4PZ USA MED RSCH ACQUIS ACT |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $4.4M |
| Current contract value | $4.4M |
| Potential contract value / ceiling | $4.4M |
| Start date | Sep 21, 2021 |
| Current end date | Sep 20, 2026 |
| Potential end date | Sep 20, 2026 |
| Latest award activity | May 7, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 7, 2025 | P00004 | $0 | IMPROVING NEUROTRAUMA BY DEPOLARIZATION INHIBITION WITH COMBINATION THERAPY |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.